
November 5, 2026
Mounjaro and Zepbound Side Effects by Dose
Mounjaro and Zepbound side effects from both US labels: nausea, diarrhea and more as percentages at 5, 10 and 15 mg, plus the signs that need a doctor.
Read the guideDose & Lose
Side effects: every Dose & Lose guide on the subject, newest first. Each one cites its sources, from prescribing information to clinical trials.

November 5, 2026
Mounjaro and Zepbound side effects from both US labels: nausea, diarrhea and more as percentages at 5, 10 and 15 mg, plus the signs that need a doctor.
Read the guide
November 4, 2026
GLP-1 constipation: label rates for Ozempic, Wegovy, Mounjaro and Zepbound against placebo, why it happens, warning signs and what to ask a prescriber.
Read the guide
November 3, 2026
GLP-1 diarrhea in the label trials: 8.5% on Ozempic to 30% on Wegovy, plus Mounjaro, Zepbound and Rybelsus rates and when to call a doctor.
Read the guide
October 25, 2026
Wegovy's label reports hair loss in 3% of trial patients vs 1% on placebo. See Zepbound, Ozempic and Mounjaro figures, causes and warning signs.
Read the guide
October 23, 2026
Ozempic nausea is reported mostly during dose escalation, with no day count on the label. See rates for four medicines and the warning signs.
Read the guide
October 22, 2026
GLP-1 side effects by week: label dose schedules beside nausea, vomiting and diarrhea rates for the doses tested, plus warning signs that need a doctor.
Read the guide
October 21, 2026
Does Zepbound make you tired? See the fatigue figures on the Zepbound, Wegovy, Mounjaro and Ozempic labels, why it may happen and which signs need a doctor.
Read the guide